Oak Ridge Investments’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-26,005
Closed -$4.63M 179
2019
Q3
$4.63M Sell
26,005
-355
-1% -$76.7K 0.35% 91
2019
Q2
$6.87M Sell
26,360
-4,421
-14% -$1.17M 0.47% 89
2019
Q1
$8.79M Buy
30,781
+3,151
+11% +$1.05M 0.56% 77
2018
Q4
$8.98M Sell
27,630
-409
-1% -$142K 0.65% 62
2018
Q3
$12.6M Sell
28,039
-23,760
-46% -$9.37M 0.7% 58
2018
Q2
$21.2M Sell
51,799
-29,151
-36% -$10.6M 1.2% 23
2018
Q1
$23.6M Sell
80,950
-23,169
-22% -$5.87M 1.31% 20
2017
Q4
$19.5M Sell
104,119
-129,594
-55% -$24.2M 0.93% 40
2017
Q3
$39.4M Sell
233,713
-199,388
-46% -$30.1M 1.6% 14
2017
Q2
$62.1M Sell
433,101
-3,839
-0.9% -$516K 1.98% 8
2017
Q1
$54.7M Sell
436,940
-70,626
-14% -$8.19M 1.84% 13
2016
Q4
$57.2M Sell
507,566
-103,676
-17% -$12M 1.85% 16
2016
Q3
$78.6M Sell
611,242
-46,547
-7% -$5.58M 2.04% 13
2016
Q2
$71.9M Sell
657,789
-59,504
-8% -$5.92M 1.85% 17
2016
Q1
$68M Sell
717,293
-3,927
-0.5% -$331K 1.72% 20
2015
Q4
$65.1M Buy
721,220
+122,568
+20% +$10.4M 1.56% 23
2015
Q3
$55.5M Buy
+598,652
New +$52.7M 1.32% 25

Other funds holding ABMD

Oak Ridge Investments's ABMD Position: Q4 2019 in Review

Oak Ridge Investments sold out of Abiomed Inc (ABMD) in Q4 2019, closing a stake of 26,005 shares — an estimated $4.63M sold.

Oak Ridge Investments first reported a position in ABMD in Q3 2015 and held it in 17 quarters. The position peaked at $78.6M in Q3 2016. 465 funds tracked by Wall St. Rank hold ABMD as of Q4 2019.

  • Oak Ridge Investments reported no remaining Abiomed Inc position as of Q4 2019 after selling out during the quarter.
  • Oak Ridge Investments sold 26,005 Abiomed Inc shares in Q4 2019, an estimated $4.63M.
  • Oak Ridge Investments first reported a position in Abiomed Inc in Q3 2015 and held it in 17 quarters.
  • Oak Ridge Investments's Abiomed Inc position peaked at $78.6M in Q3 2016.
  • 465 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2019.

Based on Oak Ridge Investments's 13F filing for Q4 2019, filed 5 Feb 2020.